• Department of General Surgery, The First Affiliated Hospital of Chongqing University of Medical Sciences, Chongqing 630042;
Export PDF Favorites Scan Get Citation

We have performed guided chemoembolization on 84 patients of moderate and advanced carcinoma of liver using adriamycin lipiodol emulsion (A/L) since 1986. Result showed that the rate of improvement of symptoms was 86.1%, in 75% cases the AFP were decreased and in 79.2% the size of tumor were reduced. The mean survival time was 10.3 months which was much higher than that of the control group (5.6 months,P lt;0.001). THe survival rates of 1/2,1,2,3 year were 89.3%,43.4%,13.5% and 3.8% respctively that were significantly higher than those of the control group (51.2%, 11.5%,0) (P lt;0.01). Three patients underwent secondary resection after using A/L chemoembolization ans gelatin spinge central embolization with a longer survival rate. This may be a good method of treatment to the nonresectable liver cancers and may also be an easy way for postoperative observation.

Citation: Luo Yizhi,Ma Shaohua,Fang Kaixian,et al.. GUIDED CHEMOEMBOLIZATION THERAPY FOR MODERATE AND ADVANCED CARCINOMA OF LIVER USING ADRIAMYCIN LIPIODOL EMULSION (A REPORT OF 884 CASES). CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 1995, 2(1): 17-20. doi: Copy